Pacific Biosciences of California, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2013
Total Assets: $136.2M
Liabilities Breakdown FY2013
Total Liabilities: $67.0M
Asset Breakdown
Total Assets: $136.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $26.4M | 19.4% |
| Accounts Receivable | $2.7M | 2.0% |
| Inventory | $10.1M | 7.4% |
| Property, Plant & Equipment | $9.2M | 6.8% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $87.8M | 64.5% |
Liabilities Breakdown
Total Liabilities: $67.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.7M | 2.6% |
| Long-Term Debt | $13.3M | 19.9% |
| Other Liabilities | $51.9M | 77.5% |